Medicine recalls, shortages and safety updates in the UK
MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 2 Oct 2026 08:50.
Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications , Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.
◀ no earlier days 26 Nov 2025Wednesday 26 November 2025 · 1 event
no later days ▶ list of days
26 Nov 2025Wednesday 26 November 2025
1 event
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive
What this means, batches, details
In total 1 event on this day.
Key
class 1 recall (risk to life)
class 2–3 recall, serious shortage, safety update
class 4 defect notification, new approval
A batch recall does not mean the medicine is withdrawn: it remains licensed, only the listed batches are affected.